(19)

(11)

EP 4 554 939 A1

(12)

(43) Date of publication: 21.05.2025 Bulletin 2025/21 (21) Application number: 23744697.6 (22) Date of filing: 12.07.2023

(51) International Patent Classification (IPC):  C07D 401/14(2006.01) A61P 9/00(2006.01) C07D 417/14(2006.01) A61K 31/506(2006.01) (52) Cooperative Patent Classification (CPC): C07D 417/14; C07D 401/14; A61P 9/00 (86) International application number: PCT/EP2023/069263 (87) International publication number: WO 2024/013209 (18.01.2024 Gazette 2024/03)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 13.07.2022 US 202263368268 P (71) Applicant: Astrazeneca AB 151 85 Södertälje (SE)	(72) Inventor: SERRANO-WU, Michael H. Belmont, Massachusetts 02478 (US) (74) Representative: AstraZeneca Intellectual Property  Eastbrook House Shaftesbury Road Cambridge CB2 8BF Cambridge CB2 8BF (GB)